Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Albert

Showing results (331-340 of 437) with videos related to

Pageof 44
Sort By:
Human Mutation|December 3, 2009
The most frequent DCLRE1C (ARTEMIS) mutations are based on homologous recombination eventsUlrich Pannicke, Manfred Hönig, Ilka Schulze, et al.
Cancer Research|November 25, 2003
Tumor suppression by a rationally designed reversible inhibitor of methionine aminopeptidase-2Jieyi Wang, George S Sheppard, Pingping Lou, et al.
Bioorganic & Medicinal Chemistry Letters|June 20, 2001
Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitorsM R Michaelides, J F Dellaria, J Gong, et al.
Bone Marrow Transplantation|March 12, 2020
The role of HLA matching in unrelated donor hematopoietic stem cell transplantation for sickle cell disease in EuropeEliane Gluckman, Josu de la Fuente, Barbara Cappelli, et al.
Journal of Clinical Immunology|May 28, 2013
A novel gain-of-function IKBA mutation underlies ectodermal dysplasia with immunodeficiency and polyendocrinopathyLena F Schimke, Nikolaus Rieber, Stacey Rylaarsdam, et al.
Journal of Medicinal Chemistry|February 12, 2008
3-amino-benzo[d]isoxazoles as novel multitargeted inhibitors of receptor tyrosine kinasesZhiqin Ji, Asma A Ahmed, Daniel H Albert, et al.
American Journal of Hematology|May 17, 2019
Allogeneic hematopoietic stem cell transplantation from unrelated donors is associated with higher infection rates in children with acute lymphoblastic leukemia-A prospective international multicenter trial on behalf of the BFM-SG and the EBMT-PDWPHerbert Pichler, Anita Lawitschka, Evgenia Glogova, et al.
Journal of Clinical Immunology|January 21, 2026
Correction to: An international survey of allogeneic hematopoietic cell transplantation for X-linked agammaglobulinemiaAkira Nishimura, Ramya Uppuluri, Revathi Raj, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2012
Pyrazole diaminopyrimidines as dual inhibitors of KDR and Aurora B kinasesMichael L Curtin, H Robin Heyman, Robin R Frey, et al.
Journal of Clinical Immunology|July 16, 2023
An International Survey of Allogeneic Hematopoietic Cell Transplantation for X-Linked AgammaglobulinemiaAkira Nishimura, Ramya Uppuluri, Revathi Raj, et al.
Pageof 44

Showing results (331-340 of 437) with videos related to

Sort By:
Pageof 44
Human Mutation|December 3, 2009
The most frequent DCLRE1C (ARTEMIS) mutations are based on homologous recombination eventsUlrich Pannicke, Manfred Hönig, Ilka Schulze, et al.
Cancer Research|November 25, 2003
Tumor suppression by a rationally designed reversible inhibitor of methionine aminopeptidase-2Jieyi Wang, George S Sheppard, Pingping Lou, et al.
Bioorganic & Medicinal Chemistry Letters|June 20, 2001
Biaryl ether retrohydroxamates as potent, long-lived, orally bioavailable MMP inhibitorsM R Michaelides, J F Dellaria, J Gong, et al.
Bone Marrow Transplantation|March 12, 2020
The role of HLA matching in unrelated donor hematopoietic stem cell transplantation for sickle cell disease in EuropeEliane Gluckman, Josu de la Fuente, Barbara Cappelli, et al.
Journal of Clinical Immunology|May 28, 2013
A novel gain-of-function IKBA mutation underlies ectodermal dysplasia with immunodeficiency and polyendocrinopathyLena F Schimke, Nikolaus Rieber, Stacey Rylaarsdam, et al.
Journal of Medicinal Chemistry|February 12, 2008
3-amino-benzo[d]isoxazoles as novel multitargeted inhibitors of receptor tyrosine kinasesZhiqin Ji, Asma A Ahmed, Daniel H Albert, et al.
American Journal of Hematology|May 17, 2019
Allogeneic hematopoietic stem cell transplantation from unrelated donors is associated with higher infection rates in children with acute lymphoblastic leukemia-A prospective international multicenter trial on behalf of the BFM-SG and the EBMT-PDWPHerbert Pichler, Anita Lawitschka, Evgenia Glogova, et al.
Journal of Clinical Immunology|January 21, 2026
Correction to: An international survey of allogeneic hematopoietic cell transplantation for X-linked agammaglobulinemiaAkira Nishimura, Ramya Uppuluri, Revathi Raj, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2012
Pyrazole diaminopyrimidines as dual inhibitors of KDR and Aurora B kinasesMichael L Curtin, H Robin Heyman, Robin R Frey, et al.
Journal of Clinical Immunology|July 16, 2023
An International Survey of Allogeneic Hematopoietic Cell Transplantation for X-Linked AgammaglobulinemiaAkira Nishimura, Ramya Uppuluri, Revathi Raj, et al.
Pageof 44